Thousand Oaks Biopharmaceuticals
Latest round
- Series C
Last raised
- Aug 2021
Total raised
- $169M
Investors
- 24
About Thousand Oaks Biopharmaceuticals
Established in 2017 and based in Nantong, China, Thousand Oaks Biopharmaceuticals, Inc. is a biopharmaceutical technology service provider that focuses on biopharmaceuticals in the fields of CRO and CMO. In 2019, the company established Thounsand Oaks Biopharmaceuticals, Inc. in the US. In 2020, the company produced COVID-19 vaccines. Dr. Shun luo, the founder and chairman of the company, worked at Serono, JRH Biosciences and Amgen. The company engages in the development of CDMO biopharmaceutical products. Its main products include a transient transfection platform, stock solutions and preparation filling, etc. The transient transfection platform provides proteins for drug screening and druggability evaluation research. In the future, the company will focus on recombinant protein, virus, nucleic acid, ADC and other fields to provide a one-stop CMC overall solution for biopharmaceutical customers.
Who invested in Thousand Oaks Biopharmaceuticals
24 investors across 4 rounds
See all investors in Thousand Oaks Biopharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Thousand Oaks Biopharmaceuticals
Who invested in Thousand Oaks Biopharmaceuticals?
Thousand Oaks Biopharmaceuticals has 24 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Thousand Oaks Biopharmaceuticals raised?
Thousand Oaks Biopharmaceuticals has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Thousand Oaks Biopharmaceuticals last raise money?
Thousand Oaks Biopharmaceuticals's most recent round on record is a Series C, in Aug 2021.
What does Thousand Oaks Biopharmaceuticals do?
Established in 2017 and based in Nantong, China, Thousand Oaks Biopharmaceuticals, Inc.
Where is Thousand Oaks Biopharmaceuticals headquartered?
Thousand Oaks Biopharmaceuticals is headquartered in Nantong, China.
Which VCs invest in companies like Thousand Oaks Biopharmaceuticals?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at Thousand Oaks Biopharmaceuticals's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series C
Raising like Thousand Oaks Biopharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.